Indivior Pharmaceuticals (INDV) EPS (Diluted) (2024 - 2026)
Indivior Pharmaceuticals' EPS (Diluted) came in at $0.98 for Q2 2026, up 588.7% from $0.14 a year earlier and up 42.6% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) EPS (Diluted) (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Indivior Pharmaceuticals reported EPS (Diluted) of $2.86, up 234.0% year-over-year; for FY2025, it came in at $1.64.
- EPS (Diluted) carries a four-year compound annual growth rate of 5.0% (FY2021 to FY2025).
- Going back by year, EPS (Diluted) was $0.05 in FY2024, -$0.92 in FY2023, -$0.30 in FY2022 and $1.35 in FY2021.
- The Q2 2026 figure represents the highest quarterly EPS (Diluted) in data going back to Q1 2024.
- Year-over-year, EPS (Diluted) has increased for four consecutive quarters, with growth averaging 231.6% over the last five quarters.
- Business Quant data shows INDV's EPS (Diluted) at $0.69 (Q1 2026), $0.80 (Q4 2025) and $0.33 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 7.94 |
| 2 | Johnson & Johnson | 618.58 Bn | 537.11 Bn | 17.26 Bn | 2.27 |
| 3 | AbbVie | 507.51 Bn | 480.62 Bn | 12.70 Bn | 2.04 |
| 4 | Merck | 364.48 Bn | 318.85 Bn | 12.21 Bn | -0.54 |
| 5 | Novartis Ag | 297.05 Bn | 261.04 Bn | 11.24 Bn | 1.67 |
| 6 | Astrazeneca | 261.93 Bn | 235.61 Bn | 12.86 Bn | 1.60 |
| 7 | Amgen | 235.60 Bn | 191.00 Bn | 7.24 Bn | 4.37 |
| 8 | Gilead Sciences | 191.42 Bn | 165.62 Bn | 6.22 Bn | -8.44 |
| 9 | Pfizer | 170.40 Bn | 117.05 Bn | 10.94 Bn | -0.04 |
| 10 | Indivior Pharmaceuticals | 4.16 Bn | 3.12 Bn | 294.00 Mn | 0.98 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.98 |
| Mar 31, 2026 | 0.69 |
| Dec 31, 2025 | 0.80 |
| Sep 30, 2025 | 0.33 |
| Jun 30, 2025 | 0.14 |
| Mar 31, 2025 | 0.38 |
| Dec 31, 2024 | 0.16 |
| Sep 30, 2024 | 0.17 |
| Jun 30, 2024 | -0.72 |
| Mar 31, 2024 | 0.45 |
API Access
Indivior Pharmaceuticals EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();